BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 25182061)

  • 1. Prolonged treatment with large doses of fosfomycin plus vancomycin and amikacin in a case of bacteraemia due to methicillin-resistant Staphylococcus epidermidis and IMP-8 metallo-β-lactamase-producing Klebsiella oxytoca.
    Vergara-López S; Domínguez MC; Conejo MC; Pascual Á; Rodríguez-Baño J
    J Antimicrob Chemother; 2015 Jan; 70(1):313-5. PubMed ID: 25182061
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative study of the mutant prevention concentrations of vancomycin alone and in combination with levofloxacin, rifampicin and fosfomycin against methicillin-resistant Staphylococcus epidermidis.
    Liu LG; Zhu YL; Hu LF; Cheng J; Ye Y; Li JB
    J Antibiot (Tokyo); 2013 Dec; 66(12):709-12. PubMed ID: 23981959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacteraemia due to OXA-48-carbapenemase-producing Enterobacteriaceae: a major clinical challenge.
    Navarro-San Francisco C; Mora-Rillo M; Romero-Gómez MP; Moreno-Ramos F; Rico-Nieto A; Ruiz-Carrascoso G; Gómez-Gil R; Arribas-López JR; Mingorance J; Paño-Pardo JR
    Clin Microbiol Infect; 2013 Feb; 19(2):E72-9. PubMed ID: 23231088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lessons from an outbreak of metallo-β-lactamase-producing Klebsiella oxytoca in an intensive care unit: the importance of time at risk and combination therapy.
    Vergara-López S; Domínguez MC; Conejo MC; Pascual Á; Rodríguez-Baño J
    J Hosp Infect; 2015 Feb; 89(2):123-31. PubMed ID: 25595832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of vancomycin serum trough concentrations and outcomes in meticillin-resistant Staphylococcus aureus bacteraemia.
    Arshad S; Shoyinka A; Chen A; Jacobsen G; Zervos M
    Int J Antimicrob Agents; 2012 Nov; 40(5):474-5. PubMed ID: 22883416
    [No Abstract]   [Full Text] [Related]  

  • 6. Pelvic abscess caused by New Delhi metallo-β-lactamase-1-producing Klebsiella oxytoca in Taiwan in a patient who underwent renal transplantation in China.
    Lai CC; Lin TL; Tseng SP; Huang YT; Wang JT; Chang SC; Teng LJ; Wang JT; Hsueh PR
    Diagn Microbiol Infect Dis; 2011 Dec; 71(4):474-5. PubMed ID: 22083082
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy and safety of fosfomycin plus imipenem versus vancomycin for complicated bacteraemia and endocarditis due to methicillin-resistant Staphylococcus aureus: a randomized clinical trial.
    Pericàs JM; Moreno A; Almela M; García-de-la-Mària C; Marco F; Muñoz P; Peña C; de Alarcón A; Del Río A; Eworo A; Cruceta A; Paré JC; Mestres CA; Miró JM;
    Clin Microbiol Infect; 2018 Jun; 24(6):673-676. PubMed ID: 29408610
    [No Abstract]   [Full Text] [Related]  

  • 8. Vancomycin-intermediate Staphylococcus epidermidis: curio or omen?
    Strausbaugh LJ
    Infect Control Hosp Epidemiol; 1999 Mar; 20(3):163-5. PubMed ID: 10100540
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy and safety of fosfomycin plus imipenem as rescue therapy for complicated bacteremia and endocarditis due to methicillin-resistant Staphylococcus aureus: a multicenter clinical trial.
    del Río A; Gasch O; Moreno A; Peña C; Cuquet J; Soy D; Mestres CA; Suárez C; Pare JC; Tubau F; Garcia de la Mària C; Marco F; Carratalà J; Gatell JM; Gudiol F; Miró JM;
    Clin Infect Dis; 2014 Oct; 59(8):1105-12. PubMed ID: 25048851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of IMP-4 metallo-beta-lactamase production and porin deficiency causes carbapenem resistance in a Klebsiella oxytoca clinical isolate.
    Chen LR; Zhou HW; Cai JC; Zhang R; Chen GX
    Diagn Microbiol Infect Dis; 2009 Oct; 65(2):163-7. PubMed ID: 19748427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of imipenem for the treatment of bacteremia due to an OXA-48-producing Klebsiella pneumoniae isolate.
    Maherault AC; Nordmann P; Therby A; Pangon B
    Clin Infect Dis; 2012 Feb; 54(4):577-8. PubMed ID: 22157173
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro activity of daptomycin and tigecycline against coagulase-negative staphylococcus blood isolates from bone marrow transplant recipients.
    Kratzer C; Rabitsch W; Hirschl AM; Graninger W; Presterl E
    Eur J Haematol; 2007 Nov; 79(5):405-9. PubMed ID: 17714506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of New Delhi metallo-β-lactamase 1 (NDM-1)-producing Klebsiella pneumoniae with putative secondary transmission from the Balkan region in the Netherlands.
    Halaby T; Reuland AE; Al Naiemi N; Potron A; Savelkoul PH; Vandenbroucke-Grauls CM; Nordmann P
    Antimicrob Agents Chemother; 2012 May; 56(5):2790-1. PubMed ID: 22330915
    [No Abstract]   [Full Text] [Related]  

  • 14. Successful treatment of NDM-1 Klebsiella pneumoniae bacteraemia in a neutropenic patient.
    Chien JM; Koh TH; Chan KS; Chuah TH; Tan TT
    Scand J Infect Dis; 2012 Apr; 44(4):312-4. PubMed ID: 22126430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous Fosfomycin Treatment for Carbapenem-Resistant Klebsiella pneumoniae in the United States.
    Simkins J; Fan J; Camargo JF; Aragon L; Frederick C
    Ann Pharmacother; 2015 Oct; 49(10):1177-8. PubMed ID: 26238469
    [No Abstract]   [Full Text] [Related]  

  • 16. Lemierre syndrome complicating multiple brain abscesses caused by extended-spectrum β-lactamase-producing Klebsiella pneumoniae cured by fosfomycin and meropenem combination therapy.
    Lee WS; Wang FD; Shieh YH; Teng SO; Ou TY
    J Microbiol Immunol Infect; 2012 Feb; 45(1):72-4. PubMed ID: 22154996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatal bacteraemia and infective endocarditis due to meticillin-resistant Staphylococcus aureus (MRSA) with rapid emergence of rifampicin resistance during vancomycin/rifampicin combination treatment.
    Liu WL; Hung YL; Lin SH; Lee PI; Hsueh PR
    Int J Antimicrob Agents; 2010 Jun; 35(6):615-6. PubMed ID: 20236804
    [No Abstract]   [Full Text] [Related]  

  • 18. Area under the concentration-time curve to minimum inhibitory concentration ratio as a predictor of vancomycin treatment outcome in methicillin-resistant Staphylococcus aureus bacteraemia.
    Jung Y; Song KH; Cho Je; Kim HS; Kim NH; Kim TS; Choe PG; Chung JY; Park WB; Bang JH; Kim ES; Park KU; Park SW; Kim HB; Kim NJ; Oh MD
    Int J Antimicrob Agents; 2014 Feb; 43(2):179-83. PubMed ID: 24315788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breakthrough bacteraemia due to tigecycline-resistant Escherichia coli with New Delhi metallo-β-lactamase (NDM)-1 successfully treated with colistin in a patient with calciphylaxis.
    Stone NR; Woodford N; Livermore DM; Howard J; Pike R; Mushtaq S; Perry C; Hopkins S
    J Antimicrob Chemother; 2011 Nov; 66(11):2677-8. PubMed ID: 21846669
    [No Abstract]   [Full Text] [Related]  

  • 20. Successful treatment of methicillin-resistant Staphylococcus epidermidis prosthetic joint infection with telavancin.
    Kaushal R; Hassoun A
    J Antimicrob Chemother; 2012 Aug; 67(8):2052-3. PubMed ID: 22544850
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.